These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8723013)

  • 1. Platelet activation by fibrinolytic agents: a potential mechanism for resistance to thrombolysis and reocclusion after successful thrombolysis.
    Leopold JA; Loscalzo J
    Coron Artery Dis; 1995 Dec; 6(12):923-9. PubMed ID: 8723013
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problems of thrombolytic therapy.
    Neilson RF; Davidson JF
    Adverse Drug React Toxicol Rev; 1996 Mar; 15(1):51-64. PubMed ID: 8920633
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiplatelet effects of fibrinolytic agents: a potential contributor to the hemostatic defect after thrombolysis.
    Kamat SG; Schafer AI
    Coron Artery Dis; 1995 Dec; 6(12):930-5. PubMed ID: 8723014
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombolysis in newborns and infants.
    Nowak-Göttl U; Auberger K; Halimeh S; Junker R; Klinge J; Kreuz WD; Ries M; Schlegel N
    Thromb Haemost; 1999 Sep; 82 Suppl 1():112-6. PubMed ID: 10695499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New thrombolytic drugs].
    Kopeć M
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):127-30. PubMed ID: 2216951
    [No Abstract]   [Full Text] [Related]  

  • 7. Theoretic and practical considerations on laboratory monitoring of thrombolytic therapy.
    Conard J; Samama MM
    Semin Thromb Hemost; 1987 Apr; 13(2):212-22. PubMed ID: 3114887
    [No Abstract]   [Full Text] [Related]  

  • 8. Lytic solution of platelet-rich plasma clots potentiated platelet response to agonists by action on Ca2+ homeostasis.
    Liao CL; Zou QJ
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):214-8. PubMed ID: 8237394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saruplase versus other fibrinolytic agents.
    Michels HR
    Int J Clin Pract Suppl; 1998 Nov; 99():21-2. PubMed ID: 10344037
    [No Abstract]   [Full Text] [Related]  

  • 10. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of fibrinolytic agents.
    Sasahara AA; Wall RT; Harburg CB
    West J Med; 1981 Feb; 134(2):128-33. PubMed ID: 7222662
    [No Abstract]   [Full Text] [Related]  

  • 12. Back-table thrombolysis in live donor kidney transplantation.
    Johari Y; Hosgood SA; Mohamed IH; Nicholson ML
    Transplantation; 2010 Mar; 89(6):765-6. PubMed ID: 20308865
    [No Abstract]   [Full Text] [Related]  

  • 13. [Arterial thrombolysis. Review and future prospects].
    Marzelle J; Combe S; Gigou F; Samama M
    J Mal Vasc; 1988; 13(4):307-16. PubMed ID: 3143794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of thrombolytic agents. Implications for therapy of coronary artery thrombosis.
    Marder VJ
    Circulation; 1983 Aug; 68(2 Pt 2):I2-5. PubMed ID: 6683134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous measurement of all thrombosis parameters from native human blood: usefulness in monitoring efficacy and complications of thrombolytic therapy.
    Kovacs IB; Görög P
    Angiology; 1990 Oct; 41(10):829-35. PubMed ID: 2121073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiating effect of clopidogrel and SR 46349, a novel 5-HT2 antagonist, on streptokinase-induced thrombolysis in the rabbit.
    Herbert JM; Bernat A; Sainte-Marie M; Dol F; Rinaldi M
    Thromb Haemost; 1993 Mar; 69(3):268-71. PubMed ID: 8470050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical and pharmacological principles of antithrombotic therapy].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):293-312. PubMed ID: 63418
    [No Abstract]   [Full Text] [Related]  

  • 18. The case for thrombolysis for iliofemoral venous thrombosis.
    Peden E; Zhou W; Bush RL; Lumsden AB; Lin PH
    Semin Vasc Surg; 2005 Sep; 18(3):139-47. PubMed ID: 16168889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrinolytic treatment with urokinase and streptokinase for recurrent thrombosis in two valve prostheses for the aortic and mitral valves during pregnancy].
    Tissot H; Vergnes C; Rougier P; Bricaud H; Dallay D
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(8):1093-6. PubMed ID: 1811007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Theoretical bases for the use of anticoagulants and thrombolytic agents].
    Samama M; Kher A
    Coeur Med Interne; 1979; 18(2):287-91. PubMed ID: 487717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.